SAFETY AND IMMUNOGENICITY OF BNT162B2 MRNA COVID-19 VACCINE AMONG ADOLESCENTS WITH RHEUMATIC DISEASES TREATED WITH IMMUNOMODULATORY MEDICATIONS

被引：0
|
作者：
Heshin-Bekenstein, M. [1 ,2 ]
Ziv, A. [2 ,3 ]
Toplak, N. [4 ]
Hagin, D. [2 ,5 ]
Kadishevich, D. [6 ]
Butbul, Y. [7 ]
Saiag, E. [8 ]
Shefer, G. [9 ]
Sharon, O. [9 ]
Pel, S. [10 ]
Elkayam, O. [2 ,10 ]
Uziel, Y. [2 ,3 ]
机构：
[1] Dana Dwek Childrens Hosp, Pediat Rheumatol Serv, Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
[3] Meir Med Ctr, Pediat Rheumatol Unit, Kefar Sava, Israel
[4] Univ Childrens Hosp, Univ Med Ctr Ljubljana, Dept Allergol Rheumatol & Clin Immunol, Ljubljana, Slovenia
[5] Tel Aviv Med Ctr & Sch Med, Allergy & Clin Immunol Unit, Tel Aviv, Israel
[6] Meir Med Ctr, Pediat, Kefar Sava, Israel
[7] Ruth Rappaport Childrens Hosp, Pediat Rheumatol Serv, Rambam Med Ctr, Haifa, Israel
[8] Tel Aviv Sourasky Med Ctr, Hosp Management, Informat & Operat Branch, Tel Aviv, Israel
[9] Tel Aviv Sourasky Med Ctr, Dept Endocrinol Metab & Hypertens, Tel Aviv, Israel
[10] Tel Aviv Sourasky Med Ctr, Dept Rheumatol, Tel Aviv, Israel
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
D O I：
10.1136/annrheumdis-2022-eular.4691
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0258
引用
收藏
页码：370 / 371
页数：2
相关论文
共 50 条
  • [41] Safety and immunogenicity of the BNT162b2 mRNA Covid-19 vaccine in patients with chronic lymphocytic leukemia: a prospective study
    Diamantopoulos, Panagiotis T.
    Stafylidis, Christos
    Vlachopoulou, Dimitra
    Kontandreopoulou, Christina-Nefeli
    Giannakopoulou, Nefeli
    Vardaka, Maria
    Mpouhla, Anthi
    Mastrogianni, Elpida
    Variami, Eleni
    Galanopoulos, Athanasios
    Pappa, Vasiliki
    Psichogiou, Mina
    Hatzakis, Angelos
    Viniou, Nora-Athina
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2022, 13
  • [42] BNT162b2 mRNA COVID-19 vaccine and booster in patients with autoimmune rheumatic diseases: a national cohort study
    Bieber, Amir
    Sagy, Iftach
    Novack, Lena
    Brikman, Shay
    Abuhasira, Ran
    Ayalon, Snait
    Novofastovski, Irina
    Abu-Shakra, Mahmoud
    Mader, Reuven
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (07) : 1028 - 1035
  • [43] Correction to: Immunogenicity and safety of the mRNA-based BNT162b2 vaccine in systemic autoimmune rheumatic diseases patients
    Yael Pri-Paz Basson
    Oshrat E. Tayer-Shifman
    Rawand Naser
    Shelly Tartakover Matalon
    Oded Kimhi
    Raz Gepstein
    Tamar Halperin
    Tomer Ziv-Baran
    Amit Ziv
    Roma Parikh
    Shaye Kivity
    Yair Levy
    Clinical Rheumatology, 2022, 41 : 3925 - 3925
  • [44] Immunogenicity and safety of the CoronaVac and BNT162b2 Covid-19 vaccine in patients with inflammatory rheumatic diseases and healthy adults: comparison of different vaccines
    Sevilay Batıbay
    Rezan Koçak Ulucaköy
    Zafer Günendi
    Işıl Fidan
    Gülendam Bozdayı
    Feride Nur Göğüş
    Inflammopharmacology, 2022, 30 : 2089 - 2096
  • [45] Immunogenicity and safety of the CoronaVac and BNT162b2 Covid-19 vaccine in patients with inflammatory rheumatic diseases and healthy adults: comparison of different vaccines
    Batibay, Sevilay
    Ulucakoy, Rezan Kocak
    Gunendi, Zafer
    Fidan, Isil
    Bozdayi, Gulendam
    Gogus, Feride Nur
    INFLAMMOPHARMACOLOGY, 2022, 30 (06) : 2089 - 2096
  • [46] IMMUNOGENICITY AND SAFETY OF THE CORONOVAC AND BNT162B2 COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES AND HEALTHY ADULTS: COMPARISON OF DIFFERENT VACCINES
    Batibay, S.
    Ulucakoy, R. Kocak
    Gunendi, Z.
    Fidan, I.
    Bozdayi, G.
    Gogus, F. N.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1692 - 1692
  • [47] Immunogenicity of BNT162b2 COVID-19 vaccine in New Zealand adults
    Priddy, Frances H.
    Williams, Michael
    Carson, Simon
    Lavender, Brittany
    Mathieson, Julia
    Frampton, Chris
    Moreland, Nicole J.
    McGregor, Reuben
    Williams, Georgia
    Brewerton, Maia
    Gell, Katie
    Ussher, James
    Le Gros, Graham
    VACCINE, 2022, 40 (34) : 5050 - 5059
  • [48] Transient Cardiac Injury in Adolescents Receiving the BNT162b2 mRNA COVID-19 Vaccine
    Snapiri, Ori
    Danziger, Chen Rosenberg
    Shirman, Nina
    Weissbach, Avichai
    Lowenthal, Alexander
    Ayalon, Itay
    Adam, Dganit
    Yarden-Bilavsky, Havatzelet
    Bilavsky, Efraim
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2021, 40 (10) : E360 - E363
  • [49] Safety and Immunogenicity Following the Second and Third Doses of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents with Juvenile-Onset Autoimmune Inflammatory Rheumatic Diseases: A Prospective Multicentre Study
    Heshin-Bekenstein, Merav
    Ziv, Amit
    Toplak, Natasa
    Lazauskas, Siman
    Kadishevich, Danielle
    Yaari, Efrat Ben-Nun
    Miller-Barmak, Adi
    Aviel, Yonatan Butbul
    Saiag, Esther
    Pel, Sara
    Elkayam, Ori
    Uziel, Yosef
    Furer, Victoria
    VACCINES, 2023, 11 (04)
  • [50] Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months
    Thomas, S. J.
    Moreira, E. D., Jr.
    Kitchin, N.
    Absalon, J.
    Gurtman, A.
    Lockhart, S.
    Perez, J. L.
    Marc, G. Perez
    Polack, F. P.
    Zerbini, C.
    Bailey, R.
    Swanson, K. A.
    Xu, X.
    Roychoudhury, S.
    Koury, K.
    Bouguermouh, S.
    Kalina, W., V
    Cooper, D.
    Frenck, R. W., Jr.
    Hammitt, L. L.
    Tureci, O.
    Nell, H.
    Schaefer, A.
    Unal, S.
    Yang, Q.
    Liberator, P.
    Tresnan, D. B.
    Mather, S.
    Dormitzer, P. R.
    Sahin, U.
    Gruber, W. C.
    Jansen, K. U.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (19): : 1761 - 1773
12345